Statin Use is Associated with Reduced Mortality in Mechanically Ventilated Patients: A Retrospective Propensity-Matched Analysis of MIMIC-III Database

[1]  T. Masuda,et al.  Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients. , 2021, JAMA.

[2]  J. Laffey,et al.  Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. , 2021, JAMA.

[3]  H. Bae,et al.  Preadmission Statin Use and 90-day Mortality in the Critically Ill: A Retrospective Association Study. , 2019, Anesthesiology.

[4]  J. Liao,et al.  The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. , 2019, Current vascular pharmacology.

[5]  Yong Zhu,et al.  Atorvastatin attenuates paraquat poisoning‐induced epithelial‐mesenchymal transition via downregulating hypoxia‐inducible factor‐1 alpha , 2018, Life sciences.

[6]  F. Kronenberg,et al.  Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials , 2018, The Lancet.

[7]  J. Laffey,et al.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. , 2018, The Lancet. Respiratory medicine.

[8]  Leo Anthony Celi,et al.  Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database , 2018, Intensive Care Medicine.

[9]  E. Sapey,et al.  Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin , 2017, American journal of respiratory and critical care medicine.

[10]  Ratender K. Singh,et al.  The Effects of Atorvastatin on Inflammatory Responses and Mortality in Septic Shock: A Single-center, Randomized Controlled Trial , 2017, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[11]  Chien-Chang Lee,et al.  A Population‐Based Cohort Study on the Drug‐Specific Effect of Statins on Sepsis Outcome , 2017, Chest.

[12]  D. A. Santos,et al.  Atorvastatin as a promising anticryptococcal agent. , 2017, International journal of antimicrobial agents.

[13]  J. Laffey,et al.  Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials , 2017, Intensive Care Medicine.

[14]  A. Deep,et al.  Pleiotropic effects of statins: A boulevard to cardioprotection , 2016 .

[15]  F. O'Gara,et al.  Is There Potential for Repurposing Statins as Novel Antimicrobials? , 2016, Antimicrobial Agents and Chemotherapy.

[16]  Peter Szolovits,et al.  MIMIC-III, a freely accessible critical care database , 2016, Scientific Data.

[17]  D. Needham,et al.  One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial , 2016, Thorax.

[18]  J. Albandar,et al.  Systematic review of the in vitro effects of statins on oral and perioral microorganisms. , 2016, European journal of oral sciences.

[19]  Jian-Dong Li,et al.  Statin-conferred enhanced cellular resistance against bacterial pore-forming toxins in airway epithelial cells. , 2015, American journal of respiratory cell and molecular biology.

[20]  T. Beißbarth,et al.  Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study , 2015, BMC Medicine.

[21]  Orlando Santana,et al.  Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: a comprehensive review. , 2015, Pulmonary pharmacology & therapeutics.

[22]  G. Perkins,et al.  Simvastatin in the acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[23]  I. Douglas,et al.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome. , 2014, The New England journal of medicine.

[24]  Shu-guang Zhang,et al.  Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies , 2014, Critical Care.

[25]  W. Zin,et al.  Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. , 2013, International immunopharmacology.

[26]  Lane F Burgette,et al.  A tutorial on propensity score estimation for multiple treatments using generalized boosted models , 2013, Statistics in medicine.

[27]  R. Bellomo,et al.  A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. , 2013, American journal of respiratory and critical care medicine.

[28]  M. Vizcaychipi,et al.  Continuation of statin therapy in patients with presumed infection. , 2012, American journal of respiratory and critical care medicine.

[29]  H. Sørensen,et al.  The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study , 2012, Critical Care.

[30]  N. Mhaidat,et al.  Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin , 2012, Annals of Clinical Microbiology and Antimicrobials.

[31]  Y. Arabi,et al.  Association between statin therapy and outcomes in critically ill patients: a nested cohort study , 2011, BMC clinical pharmacology.

[32]  J. Pugin,et al.  Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptide , 2011, Critical care.

[33]  G. Bernard,et al.  Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome* , 2011, Critical care medicine.

[34]  Christos G Mihos,et al.  Pleiotropic effects of the HMG-CoA reductase inhibitors , 2011, International journal of general medicine.

[35]  D. McAuley,et al.  A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). , 2011, American journal of respiratory and critical care medicine.

[36]  Y. Takano,et al.  Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages , 2011, Journal of Pharmacology and Experimental Therapeutics.

[37]  H. Wunsch,et al.  The epidemiology of mechanical ventilation use in the United States* , 2010, Critical care medicine.

[38]  C. Roussos,et al.  Pretreatment with atorvastatin attenuates lung injury caused by high-stretch mechanical ventilation in an isolated rabbit lung model , 2010, Critical care medicine.

[39]  N. Suttorp,et al.  Simvastatin attenuates ventilator-induced lung injury in mice , 2010, Critical care.

[40]  Vineet Chopra,et al.  Does statin use improve pneumonia outcomes? , 2009, Chest.

[41]  Alex J Sutton,et al.  Statins for the prevention and treatment of infections: a systematic review and meta-analysis. , 2009, Archives of internal medicine.

[42]  J. Backman,et al.  Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. , 2009, American journal of respiratory and critical care medicine.

[43]  Stephen R Cole,et al.  Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.

[44]  V. Debari,et al.  Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study , 2008, International journal of clinical practice.

[45]  R. Rosenson,et al.  Statins and sepsis: multiple modifications at multiple levels. , 2007, The Lancet. Infectious diseases.

[46]  M. Davidson,et al.  Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals , 2007, Current medical research and opinion.

[47]  N. Khan.  Statin therapy after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[48]  D. Grigoryev,et al.  Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[49]  高野 健一.  Successful treatment of acute lung injury with pitavastatin in septic mice : potential role of glucocorticoid receptor expression in alveolar macrophages , 2011 .

[50]  C M DRUMMOND,et al.  MECHANICAL VENTILATION. , 1964, North Carolina medical journal.